ArticleInternational journal of pharmaceutics: X2025
A novel nanomicelle based on Rebaudioside A: An oral nanoplatform with enhanced nephroprotective effect of myricetin.
Tian Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.